Genistein showed promising results, inhibiting the expression of HOTAIR (HOX transcript antisense RNA) in prostate cancer cell lines, an oncogenic lnRNA that is highly expressed in this type of malignancy. The gene discussed is HOTAIR; the disease is prostate carcinoma.